Billiontoone
AcquiredDeveloper of a molecular counter platform intended to increase the resolution of cell-free DNA testing. The company's pan-cancer tumor-naive oncology test precisely quantifies tumor burden from a blood sample to track response to therapy and its prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize the signal-to-noise ratio and detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.
What it does
We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
Next to it in Healthcare and bio · Cell-free DNA molecular diagnostics
- mFluiDXSOSV SOSV IndieBio 03
Enabling molecular detection anywhere
- Jointechlabs, Inc.SOSV SOSV IndieBio 06
Pioneering access to high-quality fat grafts, fat-derived stem cells, and cell therapies
- CYBOPlug and Play
CYBO provides products and services to understand cells deeply and to harness them widely.
- NodexusPlug and Play
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
- bitBiomePlug and Play
BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms
- セレイドセラピューティクス株式会社Plug and Play
Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
- Craif Inc.Plug and Play
Liquid biopsy startup company. Conducted cancer early diagnosis initiatives / リキッド・バイオプシーのスタートアップ企業。ガンの早期診断の取り組みを実施
- クオリプス株式会社Plug and Play
CUORiPS is a company developing new medical care based on world's cutting-edge technology originated in Japan.